scispace - formally typeset
Search or ask a question

Showing papers by "Elodie Segura published in 2021"


Journal ArticleDOI
TL;DR: A review on dietary metabolites that are agonists of the Aryl hydrocarbon Receptor (AhR) can be found in this paper, where the authors examine the physiological role of these metabolites in immune cell development and functions and their effect in inflammatory disorders.
Abstract: Accumulating evidence indicates that nutrition can modulate the immune system through metabolites, either produced by host digestion or by microbiota metabolism. In this review, we focus on dietary metabolites that are agonists of the Aryl hydrocarbon Receptor (AhR). AhR is a ligand-activated transcription factor, initially characterized for its interaction with xenobiotic pollutants. Numerous studies have shown that AhR also recognizes indoles and tryptophan catabolites originating from dietary compounds and commensal bacteria. Here, we review recent work employing diet manipulation to address the impact of nutritional AhR agonists on immune responses, both locally in the intestine and at distant sites. In particular, we examine the physiological role of these metabolites in immune cell development and functions (including T lymphocytes, innate-like lymphoid cells, and mononuclear phagocytes) and their effect in inflammatory disorders.

17 citations


Journal ArticleDOI
TL;DR: In this paper, a single-cell transcriptomics approach was used to study the maturation of TFH and TFR cells isolated from human blood, iliac lymph nodes (LNs), and tonsils.
Abstract: Germinal centers (GCs) are anatomic structures where B cells undergo affinity maturation, leading to production of high-affinity antibodies. The balance between T follicular helper (TFH) and regulatory (TFR) cells is critical for adequate control of GC responses. The study of human TFH and TFR cell development has been hampered because of the lack of in vitro assays reproducing in vivo biology, along with difficult access to healthy human lymphoid tissues. We used a single-cell transcriptomics approach to study the maturation of TFH and TFR cells isolated from human blood, iliac lymph nodes (LNs), and tonsils. As independent tissues have distinct proportions of follicular T cells in different maturation states, we leveraged the heterogeneity to reconstruct the maturation trajectory for human TFH and TFR cells. We found that the dominant maturation of TFR cells follows a bifurcated trajectory from precursor Treg cells, with one arm of the bifurcation leading to blood TFR cells and the other leading to the most mature GC TFR cells. Overall, our data provide a comprehensive resource for the transcriptomics of different follicular T cell populations and their dynamic relationship across different tissues.

17 citations


Journal ArticleDOI
TL;DR: In this paper, a population of inflammatory dendritic cells sharing phenotypic features with monocyte-derived antigen-presenting cells has been described, challenging the existence of in vivo-generated mo-DCs.

9 citations


Journal ArticleDOI
TL;DR: This paper showed that pathogen sensing through toll-like receptor (TLR) ligands increases macrophage differentiation via mTORC1 and nucleotide-binding oligomerization domain (NOD) ligand induction and miR-155 expression.
Abstract: Monocytes are rapidly recruited to inflamed tissues where they differentiate into monocyte-derived macrophages (mo-mac) or dendritic cells (mo-DC). At infection sites, monocytes encounter a broad range of microbial motifs. How pathogen recognition impacts monocyte fate decision is unclear. Here, we show, using an in vitro model allowing the simultaneous differentiation of human mo-mac and mo-DC, that viruses promote mo-mac while Mycobacteria favor mo-DC differentiation. Mechanistically, we found that pathogen sensing through toll-like receptor (TLR) ligands increases mo-mac differentiation via mTORC1. By contrast, nucleotide-binding oligomerization domain (NOD) ligands favor mo-DC through the induction of TNF-α secretion and miR-155 expression. We confirmed these results in vivo, in mouse skin and by analyzing transcriptomic data from human individuals. Overall, our findings allow a better understanding of the molecular control of monocyte differentiation and of monocyte plasticity upon pathogen sensing.

8 citations


Patent
06 Apr 2021
TL;DR: In this paper, a new anti-LSP1 (Leukocyte specific protein 1) antibody was proposed, which allows specific staining of inflammatory dendritic cells and can be used in diagnosis methods or as a medicament when conjugated to a drug.
Abstract: The present invention provides a new anti-LSP1 (Leukocyte specific protein 1) antibody. This new antibody allows the specific staining of inflammatory dendritic cells and can be used in diagnosis methods or as a medicament when conjugated to a drug.